Virios Therapeutics Announces New Social Media Profiles

ATLANTA–(BUSINESS WIRE)–Virios Therapeutics, Inc. (Nasdaq: VIRI), a clinical-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, announced today the expansion of the company’s social media platforms as well as social media disclosure. Virios has established a social presence on LinkedIn, Twitter and Facebook, where current and potential investors and other… Continue reading Virios Therapeutics Announces New Social Media Profiles